Liposome Tech regulatory update

LTIZ (Menlo Park, Calif.) filed an NDA with the FDA for DOX-SL to treat Kaposi's sarcoma in AIDS patients who cannot tolerate or have failed conventional systemic chemotherapy. DOX-SL uses LTIZ's long...